Quinupramine

Jump to: navigation, search
Quinupramine
Quinupramine.png
Clinical data
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Elimination half-life33 hours
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC21H24N2
Molar mass304.43 g/mol

WikiDoc Resources for Quinupramine

Articles

Most recent articles on Quinupramine

Most cited articles on Quinupramine

Review articles on Quinupramine

Articles on Quinupramine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Quinupramine

Images of Quinupramine

Photos of Quinupramine

Podcasts & MP3s on Quinupramine

Videos on Quinupramine

Evidence Based Medicine

Cochrane Collaboration on Quinupramine

Bandolier on Quinupramine

TRIP on Quinupramine

Clinical Trials

Ongoing Trials on Quinupramine at Clinical Trials.gov

Trial results on Quinupramine

Clinical Trials on Quinupramine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Quinupramine

NICE Guidance on Quinupramine

NHS PRODIGY Guidance

FDA on Quinupramine

CDC on Quinupramine

Books

Books on Quinupramine

News

Quinupramine in the news

Be alerted to news on Quinupramine

News trends on Quinupramine

Commentary

Blogs on Quinupramine

Definitions

Definitions of Quinupramine

Patient Resources / Community

Patient resources on Quinupramine

Discussion groups on Quinupramine

Patient Handouts on Quinupramine

Directions to Hospitals Treating Quinupramine

Risk calculators and risk factors for Quinupramine

Healthcare Provider Resources

Symptoms of Quinupramine

Causes & Risk Factors for Quinupramine

Diagnostic studies for Quinupramine

Treatment of Quinupramine

Continuing Medical Education (CME)

CME Programs on Quinupramine

International

Quinupramine en Espanol

Quinupramine en Francais

Business

Quinupramine in the Marketplace

Patents on Quinupramine

Experimental / Informatics

List of terms related to Quinupramine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Quinupramine (Kevopril, Kinupril, Adeprim, Quinuprine) is a tricyclic antidepressant (TCA) used in Europe for the treatment of depression.[1][2]

Pharmacologically, quinupramine acts in vitro as a strong muscarinic acetylcholine receptor antagonist (anticholinergic) and H1 receptor antagonist (antihistamine), moderate 5-HT2 receptor antagonist, and weak serotonin and norepinephrine reuptake inhibitor.[3] It has negligible affinity for the α1-adrenergic, α2-adrenergic, β-adrenergic, or D2 receptor.[3]

Clinically, quinupramine is reported to be stimulating similarly to imipramine, desipramine, and demexiptiline.[4] It can be inferred that its in vivo metabolites may have stronger effects on the reuptake of norepinephrine and/or serotonin than quinupramine itself.[citation needed]

References

  1. Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. p. 908. ISBN 3-88763-075-0.
  2. José Miguel Vela; Helmut Buschmann; Jörg Holenz; Antonio Párraga; Antoni Torrens (2007). Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application. Weinheim: Wiley-VCH. p. 248. ISBN 3-527-31058-4.
  3. 3.0 3.1 Sakamoto H, Yokoyama N, Kohno S, Ohata K (December 1984). "Receptor binding profile of quinupramine, a new tricyclic antidepressant". Japanese Journal of Pharmacology. 36 (4): 455–60. doi:10.1254/jjp.36.455. PMID 6098759.
  4. Kent, Angela; M. Billiard (2003). Sleep: physiology, investigations, and medicine. New York: Kluwer Academic/Plenum. p. 233. ISBN 0-306-47406-9.



Linked-in.jpg